ELF · e.l.f. Beauty

The thesis

e.l.f. Beauty's shares are modestly more likely than not to beat the S&P 500 over the next three months. At its 4 November 2026 report the company posted 51% sales growth and raised its fiscal 2027 organic sales growth outlook to 9% to 11% from 6% to 7%. The fiscal third-quarter report settles it. Earnings Whispers expects that report on 3 February 2027, and it is the first quarter with rhode fully in the year-ago comparison.

MarketBeat's 5 November 2026 summary of the earnings call reports the raise. It also reports that unit volumes contributed 31 percentage points of second-quarter growth and that e.l.f. Cosmetics gained 0.3 percentage points of market share. rhode's acquisition anniversary fell on 5 August 2026, so from the third quarter all rhode sales sit in the year-ago comparison.

The raise comes with a slower second half. Management guided second-half net sales growth of about 7% to 10%, with the third quarter above that range and the fourth quarter below it, per MarketBeat.

The price has given back part of its post-report gain. The shares closed at $113.53 on 12 November 2026, down from $118.46 the session before. That close sits above only Piper Sandler's $110 target among seven post-report targets, and below those of Evercore ISI ($115), Deutsche Bank ($117), Morgan Stanley ($125), UBS ($129), JPMorgan ($135) and Citigroup ($139). The rating is Medium because guidance rose on volume-led growth and the price now sits under most post-report targets. The guided second-half slowdown and steady officer selling limit the case.

Bullish and bearish views on e.l.f. Beauty, Inc.

The bull case on e.l.f. Beauty, Inc. (ELF), in brief: organic growth outlook raised sharply. The bear case: second-half growth falls to single digits.

Bull case

• Organic growth outlook raised sharply. MarketBeat's 5 November 2026 call summary reports fiscal 2027 organic sales growth guidance of 9% to 11%, up from 6% to 7%. Total sales growth guidance rose to 22% to 24% from 18% to 20%.
• Sales and EPS far exceeded consensus. CNBC reported on 4 November 2026 that sales rose 51% to $520.8 million, against the $470.3 million LSEG consensus. Adjusted earnings per share (EPS) were $1.21 against 60 cents expected, in what 24/7 Wall St. counted as the 31st straight quarter of sales growth.
• Volume, not price, led growth. Unit volumes added 31 percentage points of second-quarter growth and price and product mix about 20 points, per MarketBeat's call summary. The company's 10-Q filed 5 November 2026 shows quarterly revenue of $520.82 million against $343.94 million a year earlier.
• Guidance rose above Street estimates. Benzinga reported on 4 November 2026 that the fiscal 2027 sales range of $2.003–2.029 billion topped a $1.976 billion estimate. Adjusted EPS guidance of $3.82–3.86, up from $3.50–3.55, topped a $3.63 estimate, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance rose to $421–427 million from $401–407 million.
• International sales more than doubled. CNBC reported international sales up 165% in the quarter, with 25% of sales now from outside the US. rhode's Sephora launch across 19 European countries was Sephora's largest launch ever, per MarketBeat's call summary.
• Every post-report target moved up. Citigroup raised its target to $139 (Buy) and JPMorgan to $135 (Overweight) on 5 November 2026, UBS to $129 (Neutral) on 6 November 2026 and Morgan Stanley to $125 (Equal-Weight) on 10 November 2026, per Benzinga. Deutsche Bank raised its target to $117 from $105 (Hold) on 6 November 2026, per MarketScreener.

Bear case

• Second-half growth falls to single digits. Management guided second-half net sales growth of about 7% to 10%, per MarketBeat's 5 November 2026 summary, against 51% in the second quarter. The fourth quarter is guided below that range because of prior-year launches and retail expansions.
• The quarter carried one-time stocking. The 19-country European rhode launch at Sephora shipped inside the second quarter, and Earnings Whispers flagged pipeline fill tied to it on 27 October 2026. The company gave no dollar figure for that fill.
• The year-ago comparison was easy. On the fiscal Q2 2026 call on 6 November 2025, rhode contributed $52 million and sales excluding rhode fell 3% as shipments to certain retailers were paused. That weak base ended with the second quarter.
• Second-half margins are guided lower. Management guided second-half adjusted EBITDA margin to the low teens, per MarketBeat, after second-quarter adjusted EBITDA of $123 million, up 86%. Marketing and digital spending is expected at the high end of 23% to 25% of full-year sales.
• Reported earnings carry rhode earnout charges. 24/7 Wall St. reported a $17.7 million contingent consideration charge for the rhode earnout in the quarter, which held earnings to 50 cents per share under generally accepted accounting principles (GAAP), against $1.21 adjusted.
• Officers kept selling into strength. SEC Form 4 filings show the senior vice president of operations sold 8,366 shares at $110.01 on 12 October 2026, 7,926 at $110.15 on 15 October 2026 and 8,965 at an average $120.47 on 5 November 2026. The chief executive sold 47,000 shares at an average $103.31 on 1 October 2026 after exercising 71,000 options; all of these sales ran under Rule 10b5-1 trading plans.

Price setup

The shares closed at $113.53 on 12 November 2026, 7.8% below the 52-week intraday high of $123.13 set on 5 November 2026. They are up 24.2% over three months from the $91.44 close of 14 August 2026 and have recovered from a 52-week closing low of $49.57 on 5 June 2026.

The first session after the report swung widely: the shares touched the 52-week high on 5 November 2026 but closed at $109.85. Buying returned in the next two sessions, to $116.14 on 6 November 2026 and $119.35 on 9 November 2026, and the shares held near $118.50 on 10 November 2026 and 11 November 2026 before the close of $113.53 on 12 November 2026. The $109.85 close of 5 November 2026 is the post-report low.

As of 12 November 2026 the 50-day moving average was $107.10 and the 200-day moving average $82.42, with the last close above both. A close back under the 50-day average would also put the shares below the post-report low. The 14 August 2026 close marks where the post-August advance would be erased.

Catalysts ahead

• 27 November 2026: Black Friday opens the US holiday selling period, after the first e.l.f. holiday campaign launched on 2 November 2026. It starts the quarter that tests the chief executive's 'very bullish' holiday comment to CNBC; the company reports the outcome only in its third-quarter release.
• ~3 February 2027 (est.): Fiscal Q3 2027 report, date listed by Earnings Whispers and not yet confirmed by the company. It is the first quarter with rhode fully in the year-ago comparison; growth above the guided 7%–10% second-half range and an intact 9%–11% organic outlook would confirm the case.

What would change the view

A daily close below $91.44, the 14 August 2026 close, which would erase the post-August advance. A cut to fiscal 2027 sales guidance below $2.003 billion, or to organic growth guidance below 9%, at the fiscal third-quarter report would also break the case.

The risks this note tracks, each with what would confirm it:

• Growth slows more than guided once rhode is fully in the year-ago comparison and European launch stocking is behind it. Confirmed by: fiscal Q3 2027 sales growth at or below 10%, or a cut to the sales range below $2.003 billion.
• The organic growth raise proves temporary, leaving headline growth dependent on acquired and launch-driven sales. Confirmed by: fiscal 2027 organic growth guidance cut below 9%, or company disclosure of falling unit volumes at the fiscal Q3 report.
• Reinvested tariff refunds, price cuts and higher marketing squeeze second-half margins beyond the low-teens EBITDA margin guided. Confirmed by: adjusted EPS guidance cut below $3.82, or adjusted EBITDA guidance cut below $421 million.
• A tariff increase raises costs on a supply chain about three-quarters China-sourced. Confirmed by: a tariff change named in company commentary as lowering the margin or EPS outlook.
• The share price already reflects the raised guidance, with neutral-rated firms' targets of $110 to $129 close to the market price. Confirmed by: downgrades or target cuts from firms with neutral ratings such as Piper Sandler, Evercore ISI or Deutsche Bank.

What it trades with

The shares trade mainly on company reports and guidance changes, and the next one is expected in early February 2027. Between reports, they are exposed to US consumer spending through mass retailers, to tariff policy on Chinese imports, and to the pace of rhode's international rollout through Sephora. e.l.f. Hair sells through Target as its exclusive US retail partner, so one retailer's decisions gate that line. Holiday-season sell-through, starting with Black Friday on 27 November 2026, is the main business read between reports, though the company discloses it only in the third-quarter release.